These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 24440439)

  • 81. Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention?
    Kuo L; Chao TF; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28645935
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Target intensity of anticoagulation with warfarin in Japanese patients with valvular atrial fibrillation – subanalysis of the J-RHYTHM Registry.
    Kodani E; Atarashi H; Inoue H; Okumura K; Yamashita T;
    Circ J; 2015; 79(2):325-30. PubMed ID: 25492037
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation.
    Pengo V; Zasso A; Barbero F; Banzato A; Nante G; Parissenti L; John N; Noventa F; Dalla Volta S
    Am J Cardiol; 1998 Aug; 82(4):433-7. PubMed ID: 9723629
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [COMPARATIVE EFFECTIVENESS AND SAFETY OF NEW ORAL ANTICOAGULANTS AND WARFARIN IN PATIENTS WITH AGE-SPECIFIC NON-VALVULAR ATRIAL FIBRILLATION].
    Shevelev VI; Kanorsky SG
    Klin Med (Mosk); 2015; 93(7):30-6. PubMed ID: 26596056
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Influence of the concomitant use of heparin on the effects of warfarin during catheter ablation for atrial fibrillation.
    Inada K; Matsuo S; Tokutake K; Yokoyama K; Hioki M; Narui R; Ito K; Tanigawa S; Yamashita S; Tokuda M; Shibayama K; Miyanaga S; Sugimoto K; Yoshimura M; Yamane T
    Heart Vessels; 2016 Mar; 31(3):397-401. PubMed ID: 25471944
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [INTERNATIONAL NORMALIZED RATIO VALUES AND HEMORRHAGE IN HOSPITALIZED PATIENTS STARTING WARFARIN THERPY: AN OBSERVATIONAL STUDY].
    Abadi U; Ellis MH
    Harefuah; 2015 Aug; 154(8):490-3, 541-2. PubMed ID: 26480611
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Development of a novel composite stroke and bleeding risk score in patients with atrial fibrillation: the AMADEUS Study.
    Lip GYH; Lane DA; Buller H; Apostolakis S
    Chest; 2013 Dec; 144(6):1839-1847. PubMed ID: 24009027
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients.
    Shireman TI; Howard PA; Kresowik TF; Ellerbeck EF
    Stroke; 2004 Oct; 35(10):2362-7. PubMed ID: 15331796
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Secondary prevention of stroke in patients with nonvalvular atrial fibrillation: optimal intensity of anticoagulation.
    Yasaka M; Yamaguchi T
    CNS Drugs; 2001; 15(8):623-31. PubMed ID: 11524034
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Optimal INR level in Thai atrial fibrillation patients who were receiving warfarin for stroke prevention in Thailand.
    Methavigul K; Boonyapisit W
    J Med Assoc Thai; 2014 Dec; 97(12):1274-80. PubMed ID: 25764634
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Relationship between prothrombin activation fragment F1.2 and international normalized ratio in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators.
    Feinberg WM; Cornell ES; Nightingale SD; Pearce LA; Tracy RP; Hart RG; Bovill EG
    Stroke; 1997 Jun; 28(6):1101-6. PubMed ID: 9183333
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Intracranial hemorrhage and subsequent ischemic stroke in patients with atrial fibrillation: a nationwide cohort study.
    Brønnum Nielsen P; Larsen TB; Gorst-Rasmussen A; Skjøth F; Rasmussen LH; Lip GYH
    Chest; 2015 Jun; 147(6):1651-1658. PubMed ID: 25412369
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Racial Differences in Quality of Anticoagulation Therapy for Atrial Fibrillation (from the TREAT-AF Study).
    Yong C; Azarbal F; Abnousi F; Heidenreich PA; Schmitt S; Fan J; Than CT; Ullal AJ; Yang F; Phibbs CS; Frayne SM; Ho PM; Shore S; Mahaffey KW; Turakhia MP
    Am J Cardiol; 2016 Jan; 117(1):61-8. PubMed ID: 26552504
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The Quality of Anticoagulation Therapy among Warfarin-Treated Patients with Atrial Fibrillation in a Primary Health Care Setting.
    Urbonas G; Valius L; Šakalytė G; Petniūnas K; Petniūnienė I
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30650565
    [No Abstract]   [Full Text] [Related]  

  • 95. Target international normalized ratio values for preventing thromboembolic and hemorrhagic events in Japanese patients with non-valvular atrial fibrillation: results of the J-RHYTHM Registry.
    Inoue H; Okumura K; Atarashi H; Yamashita T; Origasa H; Kumagai N; Sakurai M; Kawamura Y; Kubota I; Matsumoto K; Kaneko Y; Ogawa S; Aizawa Y; Chinushi M; Kodama I; Watanabe E; Koretsune Y; Okuyama Y; Shimizu A; Igawa O; Bando S; Fukatani M; Saikawa T; Chishaki A;
    Circ J; 2013; 77(9):2264-70. PubMed ID: 23708863
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Discontinuation/Interruption of Warfarin Therapy in Patients with Nonvalvular Atrial Fibrillation.
    Spivey CA; Qiao Y; Liu X; Mardekian J; Parker RB; Phatak H; Claflin AB; Kachroo S; Abdulsattar Y; Chakrabarti A; Wang J
    J Manag Care Spec Pharm; 2015 Jul; 21(7):596-606. PubMed ID: 26108384
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Improved late survival and disability after stroke with therapeutic anticoagulation for atrial fibrillation: a population study.
    Hannon N; Callaly E; Moore A; Ní Chróinín D; Sheehan O; Marnane M; Merwick A; Kyne L; Duggan J; McCormack PM; Dolan E; Crispino-O'Connell G; Harris D; Horgan G; Williams D; Kelly PJ
    Stroke; 2011 Sep; 42(9):2503-8. PubMed ID: 21778447
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Instability of anticoagulation intensity contributes to occurrence of ischemic stroke in patients with non-rheumatic atrial fibrillation.
    Nozawa T; Asanoi H; Inoue H;
    Jpn Circ J; 2001 May; 65(5):404-8. PubMed ID: 11357868
    [TBL] [Abstract][Full Text] [Related]  

  • 99. International normalized ratio stabilization in newly initiated warfarin patients with nonvalvular atrial fibrillation.
    Nelson WW; Desai S; Damaraju CV; Lu L; Fields LE; Wildgoose P; Schein JR
    Curr Med Res Opin; 2014 Dec; 30(12):2437-42. PubMed ID: 25170587
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Out-of-range international normalized ratio values and healthcare cost among new warfarin patients with non-valvular atrial fibrillation.
    Nelson WW; Wang L; Baser O; Damaraju CV; Schein JR
    J Med Econ; 2015 May; 18(5):333-40. PubMed ID: 25549062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.